Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck

Background and purpose Patients with locally advanced SCCHN have a poor prognosis. This study investigated the prognostic value of the tumor cell expression of the fibroblast growth factor 2 (FGF-2) in patients treated with surgery followed by radiotherapy. Patients and methods The impact of FGF-2-e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Strahlentherapie und Onkologie 2014, Vol.190 (1), p.68-74
Hauptverfasser:	Rades, D., Seibold, N.D., Gebhard, M.P., Noack, F., Schild, S.E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Biomarkers, Tumor - analysis Carcinoma, Squamous Cell - chemistry Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - therapy Female Fibroblast Growth Factor 2 - analysis Germany - epidemiology Head and Neck Neoplasms - chemistry Head and Neck Neoplasms - mortality Head and Neck Neoplasms - therapy Humans Male Medicine Medicine & Public Health Middle Aged Oncology Original Article Prevalence Prognosis Radiotherapy Reproducibility of Results Retrospective Studies Risk Factors Sensitivity and Specificity Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!